Abstract:Objectives To develop and validate a diagnostic scoring system to differentiate intrahepatic mass-forming cholangiocarcinoma (IMCC) from solitary colorectal liver metastasis (CRLM). Methods A total of 366 patients (263 in the training cohort, 103 in the validation cohort) who underwent MRI examination with pathologically proven either IMCC or CRLM from two centers were included. Twenty-eight MRI features were collected. Univariate analyses and multivariate logistic regression analyses were performed to identify independent predictors for distinguishing IMCC from solitary CRLM. The independent predictors were weighted over based on regression coefficients to build a scoring system. The overall score distribution was divided into three groups to show the diagnostic probability of CRLM. Results Six independent predictors, including hepatic capsular retraction, peripheral hepatic enhancement, vessel penetrating the tumor, upper abdominal lymphadenopathy, peripheral washout at the portal venous phase, and rim enhancement at the portal venous phase were included in the system. All predictors were assigned 1 point. At a cutoff of 3 points, AUCs for this score model were 0.948 and 0.903 with sensitivities of 96.5% and 92.0%, specificities of 84.4% and 71.7%, positive predictive values of 87.7% and 75.4%, negative predictive values of 95.4% and 90.5%, and accuracies of 90.9% and 81.6% for the training and validation cohorts, respectively. An increasing trend was shown in the diagnostic probability of CRLM among the three groups based on the score. Conclusions The established scoring system is reliable and convenient for distinguishing IMCC from solitary CRLM using six MRI features. Clinical relevance statement A reliable and convenient scoring system was developed to differentiate between intrahepatic mass-forming cholangiocarcinoma from solitary colorectal liver metastasis using six MRI features. Key Points • Characteristic MRI features were identified to distinguish intrahepatic mass-forming cholangiocarcinoma (IMCC) from solitary colorectal liver metastasis (CRLM). • A model to distinguish IMCC from solitary CRLM was created based on 6 features, including hepatic capsular retraction, upper abdominal lymphadenopathy, peripheral washout at the portal venous phase, rim enhancement at the portal venous phase, peripheral hepatic enhancement, and vessel penetrating the tumor.

MRI of Small Intrahepatic Mass-Forming Cholangiocarcinoma and Atypical Small Hepatocellular Carcinoma (≤3 Cm) with Cirrhosis and Chronic Viral Hepatitis: a Comparative Study

Contrast-enhanced Multiple-Phase Imaging Features of Intrahepatic Mass-Forming Cholangiocarcinoma and Hepatocellular Carcinoma with Cirrhosis: A Comparative Study

Comparison of MRI Findings of Small Hepatocellular Carcinoma and Small Intrahepatic Mass-Forming Cholangiocarcinoma

A convenient scoring system to distinguish intrahepatic mass-forming cholangiocarcinoma from solitary colorectal liver metastasis based on magnetic resonance imaging features

Different MR Features for Differentiation of Intrahepatic Mass-Forming Cholangiocarcinoma from Hepatocellular Carcinoma According to Tumor Size

Preoperative differentiation of hepatocellular carcinoma with peripheral rim-like enhancement from intrahepatic mass-forming cholangiocarcinoma on contrast-enhanced MRI

Imaging Features Of Intrahepatic Mass-Forming Cholangiocarcinomas On Gd-Bopta-Enhanced Mri

Volumetric Apparent Diffusion Coefficient Histogram Analysis in Differentiating Intrahepatic Mass‐Forming Cholangiocarcinoma from Hepatocellular Carcinoma

MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma

Small Hepatocellular Carcinoma in Patients with Hepatitis B-induced Cirrhosis:A Comparison Between MRI and MDCT

Optimizing CT and MRI Criteria for Differentiating Intrahepatic Mass-Forming Cholangiocarcinoma and Hepatocellular Carcinoma

MRI for Hepatitis B‐Associated Intrahepatic Cholangiocarcinoma: A Multicenter Comparative Study

Diagnostic Performance of Magnetic Resonance Imaging and Contrast-Enhanced Ultrasound in Differentiating Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma: a Meta-Analysis.

MRI Features of Hepatic Sarcomatoid Carcinoma Different from Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

The Value of Contrast-Enhanced Magnetic Resonance Imaging Enhancement in the Differential Diagnosis of Hepatocellular Carcinoma and Combined Hepatocellular Cholangiocarinoma

The Value of Gd-BOPTA-enhanced MRIs and DWI in the Diagnosis of Intrahepatic Mass-Forming Cholangiocarcinoma

Values of MRI Imaging Presentations in the Hepatobiliary Phase, DWI and T2WI Sequences in Predicting Pathological Grades of Intrahepatic Mass-Forming Cholangiocarcinoma

[Comparison of Enhancement Patterns of Multi-Phase Scan of Dynamic MRI and Dynamic CT in Small Hepatocellular Carcinoma].

Intrahepatic Cholangiocarcinoma in the Setting of HBV-related Cirrhosis: Differentiation with Hepatocellular Carcinoma by Using Intravoxel Incoherent Motion Diffusion-Weighted MR Imaging

Evaluation of 3.0 T Magnetic Resonance Imaging in Detecting Small Hepatocellular Carcinoma Upon Cirrhosis Background

The Correlation of MRI Findings with Pathologic Features in Combined Hepatocellular-Cholangiocarcinoma